Rehospitalization for heart failure: Problems and perspectives

Journal of the American College of Cardiology

Volumn 61, Issue 4, 2013, Pages 391-403

  Gheorghiade, Mihai ^a   Vaduganathan, Muthiah ^b   Fonarow, Gregg C ^c   Bonow, Robert O ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UCLA MEDICAL CENTER   (United States)

Author keywords

heart failure; outcomes; readmission

Indexed keywords

ADENOSINE RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; LOOP DIURETIC AGENT; METOLAZONE; MINERALOCORTICOID ANTAGONIST; NITRATE; TOLVAPTAN; VASOPRESSIN ANTAGONIST;

ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE COURSE; EVIDENCE BASED MEDICINE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HOSPITAL READMISSION; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LEFT VENTRICULAR SYSTOLIC DYSFUNCTION; LENGTH OF STAY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SOCIAL SUPPORT; SODIUM RESTRICTION; SUDDEN DEATH; ULTRAFILTRATION; UNITED STATES;

EID: 84872678336     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.09.038     Document Type: Review

References (77)

1. S.A. Hunt, W.T. Abraham, M.H. Chin 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 53 2009 e1 e90
2. S.F. Jencks, M.V. Williams, E.A. Coleman Rehospitalizations among patients in the Medicare fee-for-service program N Engl J Med 360 2009 1418 1428
3. M. Gheorghiade, P.S. Pang Acute heart failure syndromes J Am Coll Cardiol 53 2009 557 573
4. G.C. Fonarow, W.G. Stough, W.T. Abraham Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry J Am Coll Cardiol 50 2007 768 777
5. C.M. O'Connor, A.B. Miller, J.E. Blair Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program Am Heart J 159 2010 841 849
6. J.E. Blair, P.S. Pang, R.W. Schrier Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial Eur Heart J 32 2011 2563 2572
7. G.C. Fonarow, W.T. Abraham, N.M. Albert Association between performance measures and clinical outcomes for patients hospitalized with heart failure JAMA 297 2007 61 70
8. G.M. Felker, P.S. Pang, K.F. Adams Clinical trials of pharmacological therapies in acute heart failure syndromes: lessons learned and directions forward Circ Heart Fail 3 2010 314 325
9. M. Gheorghiade, A. Ambrosy Heart failure in 2010: one step forward, two steps back Nat Rev Cardiol 8 2011 72 73
10. M. Gheorghiade, F. Zannad, G. Sopko Acute heart failure syndromes: current state and framework for future research Circulation 112 2005 3958 3968
11. M. Gheorghiade, W.T. Abraham, N.M. Albert Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure JAMA 296 2006 2217 2226
12. K.E. Joynt, E.J. Orav, A.K. Jha The association between hospital volume and processes, outcomes, and costs of care for congestive heart failure Ann Intern Med 154 2011 94 102
13. J.S. Ross, J. Chen, Z. Lin Recent national trends in readmission rates after heart failure hospitalization Circ Heart Fail 3 2010 97 103
14. J.E. Blair, F. Zannad, M.A. Konstam Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program J Am Coll Cardiol 52 2008 1640 1648
15. R.S. Bhatia, J.V. Tu, D.S. Lee Outcome of heart failure with preserved ejection fraction in a population-based study N Engl J Med 355 2006 260 269
16. C.M. O'Connor, W.T. Abraham, N.M. Albert Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) Am Heart J 156 2008 662 673
17. J.S. Rossi, J.D. Flaherty, G.C. Fonarow Influence of coronary artery disease and coronary revascularization status on outcomes in patients with acute heart failure syndromes: a report from OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Eur J Heart Fail 10 2008 1215 1223
18. M. Gheorghiade, W.T. Abraham, N.M. Albert Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry Eur Heart J 28 2007 980 988
19. R.D. Kociol, P.S. Pang, M. Gheorghiade, G.C. Fonarow, C.M. O'Connor, G.M. Felker Troponin elevation in heart failure prevalence, mechanisms, and clinical implications J Am Coll Cardiol 56 2010 1071 1078
20. N.C. Wang, A.P. Maggioni, M.A. Konstam Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction JAMA 299 2008 2656 2666
21. S.M. Dunlay, M. Gheorghiade, K.J. Reid Critical elements of clinical follow-up after hospital discharge for heart failure: insights from the EVEREST trial Eur J Heart Fail 12 2010 367 374
22. M. Gheorghiade, P.S. Pang, A.P. Ambrosy A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial Heart Fail Rev 17 2012 485 509
23. J.E. Blair, S. Khan, M.A. Konstam Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial Eur Heart J 30 2009 1666 1673
24. A.N. Shah, S. Nodari, M. Gheorghiade Biomarkers in acute heart failure syndromes: are they fulfilling their promise? Cardiology 120 2011 19 21
25. G.C. Fonarow, W.T. Abraham, N.M. Albert Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF Arch Intern Med 168 2008 847 854
26. M. Gheorghiade, G. Filippatos, L. De Luca, J. Burnett Congestion in acute heart failure syndromes: an essential target of evaluation and treatment Am J Med 119 2006 S3 S10
27. P.B. Adamson, A. Magalski, F. Braunschweig Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system J Am Coll Cardiol 41 2003 565 571
28. M. Gheorghiade, E. Braunwald A proposed model for initial assessment and management of acute heart failure syndromes JAMA 305 2011 1702 1703
29. D. Bello, D.J. Shah, G.M. Farah Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy Circulation 108 2003 1945 1953
30. F.F. Seghatol, D.J. Shah, S. Diluzio Relation between contractile reserve and improvement in left ventricular function with beta-blocker therapy in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 93 2004 854 859
31. M. Metra, M. Gheorghiade, R.O. Bonow, L. Dei Cas Postdischarge assessment after a heart failure hospitalization: the next step forward Circulation 122 2010 1782 1785
32. M. Gheorghiade, F. Follath, P. Ponikowski Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine Eur J Heart Fail 12 2010 423 433
33. S.R. Goldsmith, F. Brandimarte, M. Gheorghiade Congestion as a therapeutic target in acute heart failure syndromes Prog Cardiovasc Dis 52 2010 383 392
34. A.A. Valika, M. Gheorghiade ACE inhibitor therapy for heart failure in patients with impaired renal function: a review of the literature Heart Fail Rev 2012 Jan 2 [E-pub ahead of print]
35. G.M. Felker, K.L. Lee, D.A. Bull Diuretic strategies in patients with acute decompensated heart failure N Engl J Med 364 2011 797 805
36. R.W. Schrier, M. Gheorghiade Challenge of rehospitalizations for heart failure: potential of natriuretic doses of mineralocorticoid receptor antagonists Am Heart J 161 2011 221 223
37. F. Zannad, J.J. McMurray, H. Krum Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med 364 2011 11 21
38. M. Gheorghiade, M.A. Konstam, J.C. Burnett Jr. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST clinical status trials JAMA 297 2007 1332 1343
39. R.W. Schrier, P. Gross, M. Gheorghiade Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia N Engl J Med 355 2006 2099 2112
40. R.O. Bonow, T.G. Ganiats, C.T. Beam ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement J Am Coll Cardiol 59 2012 1812 1832
41. M. Albaghdadi, M. Gheorghiade, B. Pitt Mineralocorticoid receptor antagonism: therapeutic potential in acute heart failure syndromes Eur Heart J 32 2011 2626 2633
42. N.M. Albert, C.W. Yancy, L. Liang Use of aldosterone antagonists in heart failure JAMA 302 2009 1658 1665
43. A.L. Taylor, S. Ziesche, C. Yancy Combination of isosorbide dinitrate and hydralazine in blacks with heart failure N Engl J Med 351 2004 2049 2057
44. M. Gheorghiade, E. Braunwald Reconsidering the role for digoxin in the management of acute heart failure syndromes JAMA 302 2009 2146 2147
45. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
46. A. Ahmed, M.W. Rich, J.L. Fleg Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary Digitalis Investigation Group trial Circulation 114 2006 397 403
47. J.E. Wilcox, G.C. Fonarow, C.W. Yancy Factors associated with improvement in ejection fraction in clinical practice among patients with heart failure: findings from IMPROVE HF Am Heart J 163 2012 49 56 e2
48. K. Swedberg, M. Komajda, M. Bohm Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study Lancet 376 2010 875 885
49. A.U. Khand, A.C. Rankin, W. Martin, J. Taylor, I. Gemmell, J.G. Cleland Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol 42 2003 1944 1951
50. N.C. Wang, S. Bhattacharya, M. Gheorghiade The potential role of cardiac resynchronization therapy in acute heart failure syndromes Heart Fail Rev 16 2011 481 490
51. N.C. Wang, J.P. Piccini, M.A. Konstam Implantable cardioverter- defibrillators in patients hospitalized for heart failure with chronically reduced left ventricular ejection fraction Am J Ther 17 2010 e78 e87
52. N.A. Chatterjee, G.D. Lewis What is the prognostic significance of pulmonary hypertension in heart failure? Circ Heart Fail 4 2011 541 545
53. K.F. Adams Jr., G.C. Fonarow, C.L. Emerman Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE) Am Heart J 149 2005 209 216
54. M. Gheorghiade, E.D. Peterson Improving postdischarge outcomes in patients hospitalized for acute heart failure syndromes JAMA 305 2011 2456 2457
55. R.J. Mentz, M. Fiuzat, D.M. Wojdyla Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF Eur J Heart Fail 14 2012 395 403
56. B.A. Steinberg, X. Zhao, P.A. Heidenreich Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction - prevalence, therapies, and outcomes Circulation 126 2012 65 75
57. S.J. Shah, M. Gheorghiade Heart failure with preserved ejection fraction: treat now by treating comorbidities JAMA 300 2008 431 433
58. A.F. Hernandez, M.A. Greiner, G.C. Fonarow Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure JAMA 303 2010 1716 1722
59. L. Blue, E. Lang, J.J. McMurray Randomised controlled trial of specialist nurse intervention in heart failure BMJ 323 2001 715 718
60. H.M. Krumholz, J. Amatruda, G.L. Smith Randomized trial of an education and support intervention to prevent readmission of patients with heart failure J Am Coll Cardiol 39 2002 83 89
61. M.D. Naylor, D. Brooten, R. Campbell Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial JAMA 281 1999 613 620
62. S. Stewart, J.E. Marley, J.D. Horowitz Effects of a multidisciplinary, home-based intervention on unplanned readmissions and survival among patients with chronic congestive heart failure: a randomised controlled study Lancet 354 1999 1077 1083
63. M. Gheorghiade, R.O. Bonow Heart failure: early follow-up after hospitalization for heart failure Nat Rev Cardiol 7 2010 422 424
64. W.T. Abraham, P.B. Adamson, R.C. Bourge Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial Lancet 377 2011 658 666
65. M.W. Rich, V. Beckham, C. Wittenberg, C.L. Leven, K.E. Freedland, R.M. Carney A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure N Engl J Med 333 1995 1190 1195
66. T.M. Koelling, M.L. Johnson, R.J. Cody, K.D. Aaronson Discharge education improves clinical outcomes in patients with chronic heart failure Circulation 111 2005 179 185
67. W.F. Peacock, E. Braunwald, W. Abraham National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities J Am Coll Cardiol 56 2010 343 351
68. S.P. Collins, A.B. Storrow Acute heart failure risk stratification: can we define low risk? Heart Fail Clin 5 2009 75 83
69. J. Chen, S.L. Normand, Y. Wang, H.M. Krumholz National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008 JAMA 306 2011 1669 1678
70. P.S. Keenan, S.L. Normand, Z. Lin An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure Circ Cardiovasc Qual Outcomes 1 2008 29 37
71. A.F. Hernandez, G.C. Fonarow, L. Liang, P.A. Heidenreich, C. Yancy, E.D. Peterson The need for multiple measures of hospital quality: results from the Get with the Guidelines-Heart Failure Registry of the American Heart Association Circulation 124 2011 712 719
72. K.E. Joynt, E.J. Orav, A.K. Jha Thirty-day readmission rates for Medicare beneficiaries by race and site of care JAMA 305 2011 675 681
73. E.Z. Gorodeski, R.C. Starling, E.H. Blackstone Are all readmissions bad readmissions? N Engl J Med 363 2010 297 298
74. M. Gheorghiade, M. Vaduganathan, S.J. Greene Site selection in global clinical trials in patients hospitalized for heart failure: perceived problems and potential solutions Heart Fail Rev 2012 Oct 26 [E-pub ahead of print]
75. M. Gheorghiade, K.F. Adams, J.G. Cleland Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group Am Heart J 157 2009 957 970
76. M. Gheorghiade, M. Albaghdadi, F. Zannad Rationale and design of the multicentre, randomized, double-blind, placebo-controlled Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) Eur J Heart Fail 13 2011 100 106
77. H. Bueno, J.S. Ross, Y. Wang Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006 JAMA 303 2010 2141 2147